Company / Operating Margin
Exelixis Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
37.6%
FY2025
5-year range
9.3% / 38.2%
FY2021-FY2025
Trend
+34.8%
vs FY2024
Sector context
#10 of 135
Health Care
What the data says
Among 135 Health Care companies, Exelixis is in the top 7% for operating margin. Operating Margin has fluctuated over the past 10 years, ranging from -75.7% in FY2016 to 205.1% in FY2017.
Based on SEC 10-K filings.
37.6% in FY2025 with a 5-year CAGR of +26.5%. Top quartile in the Health Care sector.
Improved from 9.3% to 37.6% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +26.5pp
- 5-Year Change
- +26.5pp
- 10-Year Change
- -
Sector benchmark
Top 7% in Health CareTop 7% of 135This company 37.6% Sector average -774.4%
▼
+104.9% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 34.8% year-over-year.
- Currently 812.0pp above the Health Care sector average.
- Peak operating margin was recorded in FY2017.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 37.6% | +34.8% |
| FY2024 | 27.9% | +198.5% |
| FY2023 | 9.3% | -16.2% |
| FY2022 | 11.1% | -70.8% |
| FY2021 | 38.2% | +242.7% |
| FY2020 | 11.1% | -70.8% |
| FY2019 | 38.2% | +359.9% |
| FY2018 | -14.7% | -107.2% |
| FY2017 | 205.1% | +371.1% |
| FY2016 | -75.7% | +76.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026